HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.

Abstract
Coumarin and homologous compounds are the most widely used anticoagulant drugs worldwide. They function as antagonists of vitamin K, an essential cofactor for the posttranslational gamma-glutamyl carboxylation of the so-called vitamin K-dependent proteins. As vitamin K hydroquinone is converted to vitamin K epoxide (VKO) in every carboxylation step, the epoxide has to be recycled to the reduced form by the vitamin K epoxide reductase complex (VKOR). Recently, a single coumarin-sensitive protein of the putative VKOR enzyme complex was identified in humans (vitamin K epoxide reductase complex subunit 1, VKORC1). Mutations in VKORC1 result in two different phenotypes: warfarin resistance (WR) and multiple coagulation factor deficiency type 2 (VKCFD2). Here,we report on the expression of site-directed VKORC1 mutants, addressing possible structural and functional roles of all seven cysteine residues (Cys16, Cys43, Cys51, Cys85, Cys96, Cys132, Cys135), the highly conserved residue Ser/Thr57, and Arg98, known to cause VKCFD2 in humans. Our results support the hypothesis that the C132-X-X-C135 motif in VKORC1 comprises part of the redox active site that catalyzes VKO reduction and also suggest a crucial role for the hydrophobic Thr-Tyr-Ala motif in coumarin binding. Furthermore, our results support the concept that different structural components of VKORC1 define the binding sites for vitamin K epoxide and coumarin.
AuthorsSimone Rost, Andreas Fregin, Mirja Hünerberg, Carville G Bevans, Clemens R Müller, Johannes Oldenburg
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 94 Issue 4 Pg. 780-6 (Oct 2005) ISSN: 0340-6245 [Print] Germany
PMID16270630 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Coumarins
  • Disulfides
  • vitamin K1 oxide
  • Vitamin K 1
  • coumarin
  • Mixed Function Oxygenases
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases
Topics
  • Amino Acid Sequence
  • Anticoagulants (metabolism, pharmacology)
  • Binding Sites (genetics)
  • Cell Line
  • Coumarins (metabolism, pharmacology)
  • Disulfides (metabolism)
  • Drug Resistance (genetics)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Kidney (cytology)
  • Mixed Function Oxygenases (chemistry, genetics, metabolism)
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Vitamin K 1 (analogs & derivatives, metabolism)
  • Vitamin K Epoxide Reductases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: